Stuart Alan Weinzimer

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi request reprint Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes
    Stuart A Weinzimer
    Department of Pediatrics and the General Clinical Research Center, Yale University School of Medicine, New Haven, CT 06520, USA
    Pediatr Diabetes 7:15-9. 2006
  2. pmc Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA
    Diabetes Care 35:1994-9. 2012
  3. doi request reprint Closed-loop artificial pancreas: current studies and promise for the future
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    Curr Opin Endocrinol Diabetes Obes 19:88-92. 2012
  4. doi request reprint Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    Diabetes Care 31:934-9. 2008
  5. doi request reprint Sensor-augmented pump therapy in type 1 diabetes
    Stuart A Weinzimer
    Department of Pediatrics, Center for Clinical Investigation, Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    Curr Opin Endocrinol Diabetes Obes 15:118-22. 2008
  6. ncbi request reprint Insulin pump treatment of childhood type 1 diabetes
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, PO Box 208064, New Haven, CT 06520 8064, USA
    Pediatr Clin North Am 52:1677-88. 2005
  7. pmc Analysis: high-tech diabetes technology and the myth of clinical "plug and play"
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    J Diabetes Sci Technol 4:1465-7. 2010
  8. ncbi request reprint A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes
    Stuart A Weinzimer
    Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    Diabetes Care 31:210-5. 2008
  9. ncbi request reprint Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, PO Box 208064, 333 Cedar St, New Haven, Connecticut 06520, USA
    Pediatrics 114:1601-5. 2004
  10. ncbi request reprint The "hop, skip, and jump": on exercise with a continuous glucose sensor device
    Stuart Alan Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Diabetes Technol Ther 6:463-5. 2004

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes
    Stuart A Weinzimer
    Department of Pediatrics and the General Clinical Research Center, Yale University School of Medicine, New Haven, CT 06520, USA
    Pediatr Diabetes 7:15-9. 2006
    ....
  2. pmc Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA
    Diabetes Care 35:1994-9. 2012
    ..We hypothesized that delaying gastric emptying with preprandial injections of pramlintide would improve postprandial glycemia by allowing a better match between carbohydrate and insulin absorptions...
  3. doi request reprint Closed-loop artificial pancreas: current studies and promise for the future
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    Curr Opin Endocrinol Diabetes Obes 19:88-92. 2012
    ..The purpose of this review is to highlight the progress along multiple fronts to develop automated systems to improve control of type 1 diabetes...
  4. doi request reprint Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    Diabetes Care 31:934-9. 2008
    ..However, delays in insulin absorption associated with the subcutaneous route of delivery inevitably lead to large postprandial glucose excursions...
  5. doi request reprint Sensor-augmented pump therapy in type 1 diabetes
    Stuart A Weinzimer
    Department of Pediatrics, Center for Clinical Investigation, Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    Curr Opin Endocrinol Diabetes Obes 15:118-22. 2008
    ..The purpose of this review is to familiarize the reader with the new glucose sensors and discuss the literature evaluating their accuracy and effectiveness...
  6. ncbi request reprint Insulin pump treatment of childhood type 1 diabetes
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, PO Box 208064, New Haven, CT 06520 8064, USA
    Pediatr Clin North Am 52:1677-88. 2005
    ..Clinical studies of safety and efficacy of CSII in children are reviewed...
  7. pmc Analysis: high-tech diabetes technology and the myth of clinical "plug and play"
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    J Diabetes Sci Technol 4:1465-7. 2010
    ..An understanding of both of these aspects of CGM devices is necessary for placing clinical diabetes technology products into the context of how they will be used in "real life."..
  8. ncbi request reprint A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes
    Stuart A Weinzimer
    Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
    Diabetes Care 31:210-5. 2008
    ..The safety and efficacy of insulin aspart continuous subcutaneous insulin infusion (CSII) was compared with that of insulin lispro CSII in children and adolescents with type 1 diabetes...
  9. ncbi request reprint Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, PO Box 208064, 333 Cedar St, New Haven, Connecticut 06520, USA
    Pediatrics 114:1601-5. 2004
    ..The objective of this study was to analyze the CSII efficacy and safety data in very young children with type 1 diabetes from our Diabetes Clinic database...
  10. ncbi request reprint The "hop, skip, and jump": on exercise with a continuous glucose sensor device
    Stuart Alan Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Diabetes Technol Ther 6:463-5. 2004
  11. ncbi request reprint PENDRA: the once and future noninvasive continuous glucose monitoring device?
    Stuart Alan Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Diabetes Technol Ther 6:442-4. 2004
  12. ncbi request reprint Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms
    Stuart A Weinzimer
    Department of Pediatrics and Children s Clinical Research Center, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Diabetes Technol Ther 5:375-80. 2003
    ..Solutions 3.0 may be a more useful algorithm for preventing over-reading of low and high SG readings in non-diabetic children, whereas both algorithms give similar results in children with diabetes...
  13. ncbi request reprint Continuous glucose monitoring in type 1 diabetes
    Stuart A Weinzimer
    Yale University School of Medicine, Department of Pediatrics, PO Box 208064, 333 Cedar Street, New Haven, CT 06520, USA
    Curr Diab Rep 4:95-100. 2004
    ..The current "state of the art" of this technology, including accuracy, performance in clinical trials, limitations, and recommendations for use, is discussed for the two currently approved continuous glucose monitoring devices...
  14. ncbi request reprint Disease management in the young diabetic patient: glucose monitoring, coping skills, and treatment strategies
    Stuart A Weinzimer
    Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA
    Clin Pediatr (Phila) 44:393-403. 2005
    ..Overall, careful management, monitoring, and education can improve glycemic control and yield positive treatment outcomes in the child or adolescent with diabetes...
  15. ncbi request reprint Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment
    Dena Springer
    Department of Pediatrics and the General Clinical Research Center, Yale University School of Medicine, New Haven, Connecticut, USA
    J Pediatr 149:227-32. 2006
    ....
  16. pmc Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system
    Eda Cengiz
    Department of Pediatrics, Section of Pediatric Endocrinology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Diabetes Technol Ther 11:207-10. 2009
    ..It has been proposed that the first step towards a closed-loop artificial pancreas might be to use a continuous glucose sensor to automatically suspend the basal insulin delivery based on projected low sensor glucose values...
  17. pmc Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy
    Karena L Swan
    Department of Pediatrics, Section of Pediatric Endocrinology, Yale University, New Haven, Connecticut, USA
    Diabetes Care 32:240-4. 2009
    ..The purpose of this study was to examine the effect of type of insulin analog and age of insertion site on the pharmacodynamic characteristics of a standard insulin bolus in youth with type 1 diabetes receiving insulin pump therapy...
  18. pmc Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes
    Eda Cengiz
    Division of Pediatric Endocrinology, Yale University School of Medicine, New Haven, Connecticut, USA
    Diabetes Care 33:1009-12. 2010
    ....
  19. ncbi request reprint Decompensated hyperglycemic hyperosmolarity without significant ketoacidosis in the adolescent and young adult population
    Michael F Canarie
    Section of Critical Care Medicine, Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA
    J Pediatr Endocrinol Metab 20:1115-24. 2007
    ..To identify patients aged 10-30 years with probable hyperglycemic hyperosmolar syndrome (HHS), to describe demographic and clinical profiles, and to attempt to assess risk factors for poor outcomes...
  20. ncbi request reprint Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes
    Karena L Swan
    Section of Pediatric Endocrinology, Yale University, New Haven, Connecticut 06520, USA
    Diabetes Care 31:44-6. 2008
  21. ncbi request reprint Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects
    Susan Riddle Brian
    Department of Endocrinology, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    J Clin Endocrinol Metab 92:3374-7. 2007
    ..Our objective was to describe the first case of the successful use of pegvisomant during pregnancy in a woman with acromegaly...
  22. ncbi request reprint Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes
    William V Tamborlane
    Department of Pediatrics and General Clinical Research Center, Yale University School of Medicine, New Haven, CT, USA
    Diabetes Res Clin Pract 74:S112-5. 2006
    ..Clinical studies of safety and efficacy of CSII in children are reviewed...
  23. ncbi request reprint The renaissance of insulin pump treatment in childhood type 1 diabetes
    William V Tamborlane
    General Clinical Research Center, Yale University School of Medicine, New Haven, CT 06520 8064, USA
    Rev Endocr Metab Disord 7:205-13. 2006
    ..Clinical studies of safety and efficacy of CSII in children are reviewed, as well as criteria for patient selection and practical considerations using pump therapy in youth with T1DM...
  24. ncbi request reprint A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine
    Elizabeth A Doyle
    Department of Pediatrics and Children s Clinical Research Center, Yale University School of Medicine, New Haven, Connecticut, USA
    Diabetes Care 27:1554-8. 2004
    ..Our principal aim in this short-term study was to compare the efficacy of CSII to MDI with glargine in lowering HbA(1c) levels in children and adolescents with type 1 diabetes...
  25. ncbi request reprint Clinical outcomes and cost-effectiveness of retinopathy screening in youth with type 1 diabetes
    Betty Huo
    Department of Pediatric Endocrinology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
    Diabetes Care 30:362-3. 2007
  26. ncbi request reprint Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes*
    Shannon H Fourtner
    Department of Pediatrics, Division of Endocrinology Diabetes, Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Pediatr Diabetes 6:129-35. 2005
    ..The standard diagnostic criteria of blood glucose >600 mg/dL and serum osmolality >330 mOsm/L with only mild acidosis (serum bicarbonate >15 mmol/L and small ketonuria 15 mg/dL or less) were utilized...
  27. ncbi request reprint A 12-day-old infant with hypoglycemia
    Coeurlida Louis
    Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Curr Opin Pediatr 15:333-7. 2003

Research Grants5

  1. Yale Study of Closed-Loop Automated Glucose Control for Hypoglycemia Prevention
    Stuart Weinzimer; Fiscal Year: 2007
    ..abstract_text> ..
  2. Closed-Loop Effectiveness and Ambulatory Regimens (CLEAR)
    Stuart Weinzimer; Fiscal Year: 2009
    ....
  3. Closed-Loop Effectiveness and Ambulatory Regimens (CLEAR)
    Stuart A Weinzimer; Fiscal Year: 2010
    ....